55 patents
Page 3 of 3
Utility
Anti-methanogenic Compositions and Uses Thereof
14 Oct 20
The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS).
Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
Filed: 26 Apr 20
Utility
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
5 Oct 20
This invention provides, in part, various compositions and methods for protecting the gastrointestinal microbiome from antibiotic disruption.
Michael Kaleko, Sheila Connelly, Vincent John Wacher
Filed: 9 Jul 18
Utility
Safe and Effective Beta-lactamase Dosing for Microbiome Protection
23 Sep 20
The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
Joseph Sliman
Filed: 3 Jun 20
Utility
Beta-lactamases with improved properties for therapy
7 Sep 20
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).
Michael Kaleko, Sheila Connelly
Filed: 23 Jan 20
Utility
Anti-methanogenic lovastatin analogs or derivatives and uses thereof
10 Aug 20
The present invention relates to, in part, methods for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS) using at least one anti-methanogenic lovastatin analog or derivative.
Mark Pimentel, Vince Wacher
Filed: 30 Mar 16
Utility
Carbapenemases for Use with Antibiotics for the Protection of the Intestinal Microbiome
15 Jul 20
This invention relates, in part, to various compositions and methods for protecting the gastrointestinal microbiome from antibiotic disruption.
Michael KALEKO, Sheila CONNELLY
Filed: 18 Dec 19
Utility
Safe and effective beta-lactamase dosing for microbiome protection
13 Jul 20
The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
Joseph Sliman
Filed: 6 Mar 16
Utility
Anti-methanogenic compositions and uses thereof
1 Jun 20
The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS).
Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
Filed: 6 May 19
Utility
Beta-lactamases with Improved Properties for Therapy
20 May 20
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).
Michael KALEKO, Sheila CONNELLY
Filed: 23 Jan 20
Utility
Beta-lactamase Formulations
8 Apr 20
The present invention provides, in part, formulations comprising a beta-lactamase.
Andrew BRISTOL, Klaus GOTTLIEB, J. Blair WEST
Filed: 19 Mar 18
Utility
Beta-lactamases with improved properties for therapy
9 Mar 20
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).
Michael Kaleko, Sheila Connelly
Filed: 15 May 19
Utility
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
3 Feb 20
This invention relates, in part, to various compositions and methods for protecting the gastrointestinal microbiome from antibiotic disruption.
Michael Kaleko, Sheila Connelly
Filed: 8 Jan 18
Utility
Beta-lactamases with Improved Properties for Therapy
15 Jan 20
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).
Michael KALEKO, Sheila Connelly
Filed: 15 May 19
Utility
Humanized pertussis antibodies and used thereof
6 Jan 20
The present invention relates to humanized antibodies which bind the pertussis toxin protein and their use as therapeutic agents.
Jennifer Maynard, Annalee Nguyen, Eduardo Padlan, Ellen Wagner
Filed: 24 Jun 18
Utility
Anti-methanogenic Compositions and Uses Thereof
30 Oct 19
The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS).
Mark Pimentel, Ruchi Mathur, Steve Kanzer, Vince Wacher
Filed: 6 May 19